Clinical studies, including the STEP trial extensions, have demonstrated that many patients experience gradual weight increase after stopping treatment
Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A
Det gr det lettere at planlgge sessioner, srligt hvis du foretrkker klassiske bordspil frem for video-slots
A large observational study published in mid-2025 reported that diabetic patients using GLP-1 drugs experienced a two- to threefold increased risk of developing nAMD compared to non-users